[go: up one dir, main page]

GB201404301D0 - Compounds and combinations - Google Patents

Compounds and combinations

Info

Publication number
GB201404301D0
GB201404301D0 GB201404301A GB201404301A GB201404301D0 GB 201404301 D0 GB201404301 D0 GB 201404301D0 GB 201404301 A GB201404301 A GB 201404301A GB 201404301 A GB201404301 A GB 201404301A GB 201404301 D0 GB201404301 D0 GB 201404301D0
Authority
GB
United Kingdom
Prior art keywords
combinations
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201404301A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NEW PHARMA LICENCE HOLDINGS LIMITED
Original Assignee
CANTAB ANTI INFECTIVES Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CANTAB ANTI INFECTIVES Ltd filed Critical CANTAB ANTI INFECTIVES Ltd
Priority to GB201404301A priority Critical patent/GB201404301D0/en
Publication of GB201404301D0 publication Critical patent/GB201404301D0/en
Priority to US14/892,757 priority patent/US10407467B2/en
Priority to TW103117787A priority patent/TWI665218B/en
Priority to PCT/GB2014/051547 priority patent/WO2014188178A1/en
Priority to CN201480029145.2A priority patent/CN105308065B/en
Priority to PL14726731.4T priority patent/PL2999711T3/en
Priority to LTEPPCT/GB2014/051547T priority patent/LT2999711T/en
Priority to PT147267314T priority patent/PT2999711T/en
Priority to DK14726731.4T priority patent/DK2999711T3/en
Priority to ES14726731T priority patent/ES2923762T3/en
Priority to CA2939061A priority patent/CA2939061C/en
Priority to RS20220760A priority patent/RS63484B1/en
Priority to JP2016514479A priority patent/JP6643758B2/en
Priority to HK16109519.5A priority patent/HK1221474B/en
Priority to HRP20220898TT priority patent/HRP20220898T1/en
Priority to EP14726731.4A priority patent/EP2999711B1/en
Priority to SI201431984T priority patent/SI2999711T1/en
Priority to KR1020157035048A priority patent/KR102354902B1/en
Priority to HUE14726731A priority patent/HUE059544T2/en
Priority to BR112015029309A priority patent/BR112015029309A2/en
Priority to RU2015148032A priority patent/RU2730012C2/en
Priority to PT157151721T priority patent/PT3116897T/en
Priority to RU2016139978A priority patent/RU2740190C2/en
Priority to KR1020167027152A priority patent/KR20160135739A/en
Priority to EP15715172.1A priority patent/EP3116897B1/en
Priority to ARP150100724A priority patent/AR099714A1/en
Priority to KR1020237036093A priority patent/KR20230152779A/en
Priority to LTEPPCT/EP2015/055046T priority patent/LT3116897T/en
Priority to MX2016011682A priority patent/MX359104B/en
Priority to DK15715172.1T priority patent/DK3116897T3/en
Priority to CA2940455A priority patent/CA2940455C/en
Priority to TW104107773A priority patent/TWI709575B/en
Priority to SI201531832T priority patent/SI3116897T1/en
Priority to CN201580011858.0A priority patent/CN106232617B/en
Priority to HRP20220387TT priority patent/HRP20220387T1/en
Priority to AU2015228898A priority patent/AU2015228898B2/en
Priority to PL15715172T priority patent/PL3116897T3/en
Priority to US15/125,415 priority patent/US20170073373A1/en
Priority to RS20220387A priority patent/RS63138B1/en
Priority to JP2016556784A priority patent/JP6785659B2/en
Priority to PCT/EP2015/055046 priority patent/WO2015135976A1/en
Priority to ES15715172T priority patent/ES2910072T3/en
Priority to IL247243A priority patent/IL247243B/en
Priority to US17/157,393 priority patent/US20210221848A1/en
Priority to CY20221100299T priority patent/CY1125175T1/en
Priority to US18/126,270 priority patent/US20230322858A1/en
Ceased legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
GB201404301A 2013-05-22 2014-03-11 Compounds and combinations Ceased GB201404301D0 (en)

Priority Applications (46)

Application Number Priority Date Filing Date Title
GB201404301A GB201404301D0 (en) 2014-03-11 2014-03-11 Compounds and combinations
RU2015148032A RU2730012C2 (en) 2013-05-22 2014-05-21 Polymyxin derivatives and use thereof in a combined therapy together with various antibiotics
DK14726731.4T DK2999711T3 (en) 2013-05-22 2014-05-21 Polymyxin derivatives and their use in combination therapy with various antibiotics
CA2939061A CA2939061C (en) 2013-05-22 2014-05-21 Polymyxin derivatives and their use in combination therapy together with different antibiotics
PCT/GB2014/051547 WO2014188178A1 (en) 2013-05-22 2014-05-21 Polymyxin derivatives and their use in combination therapy together with different antibiotics
CN201480029145.2A CN105308065B (en) 2013-05-22 2014-05-21 Polymyxin derivatives and their use in combination therapy with different antibiotics
PL14726731.4T PL2999711T3 (en) 2013-05-22 2014-05-21 Polymyxin derivatives and their use in combination therapy together with different antibiotics
LTEPPCT/GB2014/051547T LT2999711T (en) 2013-05-22 2014-05-21 Polymyxin derivatives and their use in combination therapy together with different antibiotics
PT147267314T PT2999711T (en) 2013-05-22 2014-05-21 Polymyxin derivatives and their use in combination therapy together with different antibiotics
US14/892,757 US10407467B2 (en) 2013-05-22 2014-05-21 Polymyxin derivatives and their use in combination therapy together with different antibiotics
ES14726731T ES2923762T3 (en) 2013-05-22 2014-05-21 Polymyxin derivatives and their use in combination therapy with different antibiotics
TW103117787A TWI665218B (en) 2013-05-22 2014-05-21 Polymyxin compounds, pharmaceutical copmpositions comprising the same, and use of the same
RS20220760A RS63484B1 (en) 2013-05-22 2014-05-21 POLYMYXIN DERIVATIVES AND THEIR USE IN COMBINATION THERAPY TOGETHER WITH DIFFERENT ANTIBIOTICS
JP2016514479A JP6643758B2 (en) 2013-05-22 2014-05-21 Polymyxin derivatives and their use in combination therapy with different antibiotics
HK16109519.5A HK1221474B (en) 2013-05-22 2014-05-21 Polymyxin derivatives and their use in combination therapy together with different antibiotics
HRP20220898TT HRP20220898T1 (en) 2013-05-22 2014-05-21 Polymyxin derivatives and their use in combination therapy together with different antibiotics
EP14726731.4A EP2999711B1 (en) 2013-05-22 2014-05-21 Polymyxin derivatives and their use in combination therapy together with different antibiotics
SI201431984T SI2999711T1 (en) 2013-05-22 2014-05-21 Polymyxin derivatives and their use in combination therapy together with different antibiotics
KR1020157035048A KR102354902B1 (en) 2013-05-22 2014-05-21 Polymyxin derivatives and their use in combination therapy together with different antibiotics
HUE14726731A HUE059544T2 (en) 2013-05-22 2014-05-21 Polymyxin derivatives and their use in combination therapy together with different antibiotics
BR112015029309A BR112015029309A2 (en) 2013-05-22 2014-05-21 polymyxin derivatives and their use in combination therapy with different antibiotics
ES15715172T ES2910072T3 (en) 2014-03-11 2015-03-11 Polymyxin derivatives and their use in combination therapy with different antibiotics
HRP20220387TT HRP20220387T1 (en) 2014-03-11 2015-03-11 Polymyxin derivatives and their use in combination therapy together with different antibiotics
PT157151721T PT3116897T (en) 2014-03-11 2015-03-11 Polymyxin derivatives and their use in combination therapy together with different antibiotics
KR1020167027152A KR20160135739A (en) 2014-03-11 2015-03-11 Polymyxin derivatives and their use in combination therapy together with different antibiotics
EP15715172.1A EP3116897B1 (en) 2014-03-11 2015-03-11 Polymyxin derivatives and their use in combination therapy together with different antibiotics
ARP150100724A AR099714A1 (en) 2014-03-11 2015-03-11 COMPOUNDS DERIVED FROM POLYMIXIN AND ITS USE AS SPECTRO ANTIBIOTICS
KR1020237036093A KR20230152779A (en) 2014-03-11 2015-03-11 Polymyxin derivatives and their use in combination therapy together with different antibiotics
LTEPPCT/EP2015/055046T LT3116897T (en) 2014-03-11 2015-03-11 POLYMIXIN DERIVATIVES AND THEIR USE IN COMPLEX THERAPY WITH DIFFERENT ANTIBIOTICS
MX2016011682A MX359104B (en) 2014-03-11 2015-03-11 Polymyxin derivatives and their use in combination therapy together with different antibiotics.
DK15715172.1T DK3116897T3 (en) 2014-03-11 2015-03-11 Polymyxin derivatives and their use in combination therapy with various antibiotics
CA2940455A CA2940455C (en) 2014-03-11 2015-03-11 Polymyxin derivatives and their use in combination therapy together with different antibiotics
TW104107773A TWI709575B (en) 2014-03-11 2015-03-11 Polymyxin derivatives and their use in combination therapy together with different antibiotics
SI201531832T SI3116897T1 (en) 2014-03-11 2015-03-11 Polymyxin derivatives and their use in combination therapy together with different antibiotics
CN201580011858.0A CN106232617B (en) 2014-03-11 2015-03-11 Polymyxin derivatives and their use in combination therapy with different antibiotics
RU2016139978A RU2740190C2 (en) 2014-03-11 2015-03-11 Polymyxin derivatives and use thereof in a combined therapy together with various antibiotics
AU2015228898A AU2015228898B2 (en) 2014-03-11 2015-03-11 Polymyxin derivatives and their use in combination therapy together with different antibiotics
PL15715172T PL3116897T3 (en) 2014-03-11 2015-03-11 Polymyxin derivatives and their use in combination therapy together with different antibiotics
US15/125,415 US20170073373A1 (en) 2014-03-11 2015-03-11 Polymyxin derivatives and their use in combination therapy together with different antibiotics
RS20220387A RS63138B1 (en) 2014-03-11 2015-03-11 Polymyxin derivatives and their use in combination therapy together with different antibiotics
JP2016556784A JP6785659B2 (en) 2014-03-11 2015-03-11 Polymyxin derivatives and their use in combination therapies with different antibiotics
PCT/EP2015/055046 WO2015135976A1 (en) 2014-03-11 2015-03-11 Polymyxin derivatives and their use in combination therapy together with different antibiotics
IL247243A IL247243B (en) 2014-03-11 2016-08-11 Polymyxin derivatives and their use in combination therapy together with different antibiotics
US17/157,393 US20210221848A1 (en) 2014-03-11 2021-01-25 Polymyxin derivatives and their use in combination therapy together with different antibiotics
CY20221100299T CY1125175T1 (en) 2014-03-11 2022-04-20 POLYMYXIN DERIVATIVES AND THEIR USE IN COMBINATION THERAPY WITH DIFFERENT ANTIBIOTICS
US18/126,270 US20230322858A1 (en) 2014-03-11 2023-03-24 Polymyxin derivatives and their use in combination therapy together with different antibiotics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201404301A GB201404301D0 (en) 2014-03-11 2014-03-11 Compounds and combinations

Publications (1)

Publication Number Publication Date
GB201404301D0 true GB201404301D0 (en) 2014-04-23

Family

ID=50554897

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201404301A Ceased GB201404301D0 (en) 2013-05-22 2014-03-11 Compounds and combinations

Country Status (2)

Country Link
AR (1) AR099714A1 (en)
GB (1) GB201404301D0 (en)

Also Published As

Publication number Publication date
AR099714A1 (en) 2016-08-10

Similar Documents

Publication Publication Date Title
DK3237446T3 (en) Anti-PD-1-antistoffer
DK3236972T3 (en) Antivirale N4-hydroxycytidin-derivativer
DK3373003T3 (en) Urinteststrimmel
IL252216B (en) Difluoromethyl-aminopyridines and difluoromethyl-aminopyrimidines
SI3215147T1 (en) Neuro-attenuating norketamine compounds and methods
AU361515S (en) Dishrack
AU362944S (en) Lapboard
PT3122358T (en) Combinations
IL251107A0 (en) Compounds and methods
DK3191586T3 (en) Cellobiosephosphorylase
DK3178931T3 (en) Anti-orai1-antistof
DK3002465T3 (en) Hydrauliksystem
DK3145380T3 (en) Toiletventilationssystem
DK3234061T3 (en) Nano-inhibitorer
GB201404301D0 (en) Compounds and combinations
AU5585P (en) Lanutah Mandevilla sanderi
AU5598P (en) Lanidaho Mandevilla sanderi
AU5594P (en) Lanoregon Mandevilla sanderi
AU5593P (en) Lanmissouri Mandevilla sanderi
AU5597P (en) Lancalifornia Mandevilla sanderi
AU5596P (en) Lannevada Mandevilla sanderi
AU5584P (en) Laniowa Mandevilla sanderi
AU5583P (en) Lanminnesota Mandevilla sanderi
AU5591P (en) Lanmontana Mandevilla sanderi
AU5285P (en) FLOMANRER Mandevilla sanderi

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: NEW PHARMA LICENCE HOLDINGS LIMITED

Free format text: FORMER OWNER: CANTAB ANTI-INFECTIVES LIMITED

AT Applications terminated before publication under section 16(1)